{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:14:05Z","timestamp":1762100045073},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1053\/shem.2003.50032","type":"journal-article","created":{"date-parts":[[2003,4,7]],"date-time":"2003-04-07T20:38:49Z","timestamp":1049747929000},"page":"30-33","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Transplant decision-making strategies in the myeloproliferative disorders"],"prefix":"10.1053","volume":"40","author":[{"given":"Steven M.","family":"Fruchtman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/shem.2003.50032_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V26.5.657.657","article-title":"An epidemiological study of polycythemia vera","volume":"26","author":"Modan","year":"1965","journal-title":"Blood"},{"key":"10.1053\/shem.2003.50032_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0609.2000.065004267.x","article-title":"Incidence of chronic myeloproliferative disorders in the city of Goteborg, Sweden 1983-1992","volume":"65","author":"Ridell","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1053\/shem.2003.50032_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0369-8114(00)00023-7","article-title":"Epidemiology of the myeloproliferative disorders: Essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis","volume":"49","author":"Kutti","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"10.1053\/shem.2003.50032_bib4","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/shem.2003.50032_bib5","first-page":"102","article-title":"Treatment of polycythemia vera: A Summary of clinical trials conducted by the Polycythemia Vera Study Group","author":"Berk","year":"1995"},{"key":"10.1053\/shem.2003.50032_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.1994.tb01303.x","article-title":"Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications","volume":"52","author":"Weinfeld","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1053\/shem.2003.50032_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6","article-title":"Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"52","author":"Nand","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1053\/shem.2003.50032_bib8","first-page":"17","article-title":"From efficacy to safety: A Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera","volume":"34","author":"Fruchtman","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1053\/shem.2003.50032_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: High proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1053\/shem.2003.50032_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","article-title":"Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: Long-term follow-up of a randomized clinical trial","volume":"110","author":"Finazzi","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2003.50032_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/028418602317314064","article-title":"Symptoms, symptom distress and health-related quality of life in patients with polycythaemia vera or essential thrombocythaemia during treatment with interferon-alpha","volume":"41","author":"Merup","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1053\/shem.2003.50032_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2141.1997.1722990.x","article-title":"Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases","volume":"98","author":"Reilly","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2003.50032_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(97)90022-9","article-title":"Idiopathic myelofibrosis: Pathogenesis, natural history and management","volume":"11","author":"Reilly","year":"1997","journal-title":"Blood Rev"},{"key":"10.1053\/shem.2003.50032_bib14","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood.V97.7.2180","article-title":"Splenectomy and hemopoietic stem cell transplantation for myelofibrosis","volume":"97","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1053\/shem.2003.50032_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","article-title":"Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia","volume":"113","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2003.50032_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2141.2001.03131.x","article-title":"Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia","volume":"115","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2003.50032_bib17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.leu.2402108","article-title":"Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia","volume":"15","author":"Lezon-Geyda","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/shem.2003.50032_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.2830150405","article-title":"Increased serum procollagen III aminoterminal peptide in myelofibrosis","volume":"15","author":"Hochweiss","year":"1983","journal-title":"Am J Hematol"},{"key":"10.1053\/shem.2003.50032_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.2001.02584.x","article-title":"Haematopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia","volume":"112","author":"Jurado","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303807230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303807230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:23:28Z","timestamp":1584537808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196303807230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":19,"alternative-id":["S0037196303807230"],"URL":"https:\/\/doi.org\/10.1053\/shem.2003.50032","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}